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Among the Candida species causing bloodstream infections, Candida parapsilosis is one of the most frequently
isolated. The objective of the present work was the identification of new microsatellite loci able to distinguish
among C. parapsilosis isolates. DNA sequences with trinucleotide repeats were selected from the C. parapsilosis
genome database. PCR primer sets flanking the microsatellite repeats were designed and tested with 20
independent isolates. On the basis of the amplification efficiency, specificity, and observed polymorphism, four
of the sequences were selected for strain typing. Two hundred thirty-three independent C. parapsilosis sensu
stricto isolates were genotyped by using these markers. The polymorphic loci exhibited from 20 to 42 alleles and
39 to 92 genotypes. In a multiplex analysis, 192 genotypes were obtained and the combined discriminatory
power of the four microsatellites was 0.99. Reproducibility was demonstrated by submission of subcultures of
4 isolates each, in triplicate, interspersed with unique numbers among a group of 30 isolates for blind testing.
Comparison of the genotypes obtained by microsatellite analysis and those obtained by randomly amplified
polymorphic DNA analysis, restriction fragment length polymorphism analysis, and internal transcribed
sequence grouping was performed and showed that the microsatellite method could distinguish individual
isolates; none of the other methods could do that. Related species, C. orthopsilosis and C. metapsilosis, were not
confused with C. parapsilosis sensu stricto. These new microsatellites are a valuable tool for use for the
differentiation of C. parapsilosis sensu stricto strains, vital in epidemiology to answer questions of strain
relatedness and determine pathways of transmission.
Species of the genus Candida are the agents that are the
most frequently implicated in invasive fungal infections, pres-
ently ranking as the third most common cause of nosocomial
bloodstream infections in the United States (26, 27). In Europe
and Latin America, Candida parapsilosis is a predominant spe-
cies found in patients with systemic infections and causes up to
45% of all cases of candidemia (1, 37). This yeast causes sev-
eral infections in humans, including a variety of life-threaten-
ing conditions triggered by bloodstream infections; and it has
been associated with catheters, hyperalimentation, premature
birth, and contaminated prosthetic devices (23, 40). C. parap-
silosis is particularly isolated from cultures of blood from ill
neonates and children (20, 23), surgical intensive care unit
patients (17), as well as hematological patients (7, 31). Unlike
other Candida species, C. parapsilosis has been found on the
hands of health care workers, who install and maintain medical
devices, suggesting a potential route for transmission (41). The
rapid identification of the strains involved in the infection and
the elucidation of their patterns of genetic diversity are issues
of great medical relevance since such knowledge can contrib-
ute to the development of new strategies for the prevention
and treatment of the infections.
Physiologically indistinguishable isolates of C. parapsilosis
have been reported to be genetically heterogeneous. Several
reports suggested that C. parapsilosis is composed of three
distinct groups, groups I, II, and III, on the basis of isoenzyme
analysis, random amplification of polymorphic DNA (RAPD)
analysis, analysis of the nucleotide sequence of the internal
transcribed sequence (ITS) (16, 19, 21, 25), and DNA-DNA
hybridization studies (30). Tavanti et al. (36) proposed that the
three different C. parapsilosis groups be considered different
species on the basis of these observations and the degree of
sequence variation observed among groups. Group I isolates
maintained the former name, C. parapsilosis (sensu stricto),
and groups II and III included the strains to which the new
names C. orthopsilosis and C. metapsilosis, respectively, have
been proposed. The vast majority of clinical isolates belong to
C. parapsilosis group I, characterized by low levels of nucleo-
tide sequence variation, which constitutes a challenge for the
development of genotyping techniques.
The aim of the work described here was to identify and
describe new polymorphic microsatellite loci in the genome of
the pathogenic yeast C. parapsilosis and evaluate their appli-
cability for use as molecular markers for the differentiation of
isolates. The performance of this typing method was assessed
by comparison of the results to the results obtained by using
three previously described typing methods.
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MATERIALS AND METHODS
Microsatellite selection and PCR primer design. A search of C. parapsilosis
genome sequences available in databases from the Sanger Institute (http://www
.sanger.ac.uk/cgi-bin/blast/submitblast/c_parapsilosis) was performed to identify
sequences containing more than 20 tri- or tetramicrosatellite repeat units which
were expected to have very high degrees of polymorphism. Eleven microsatellites
were selected, and primers specific for the nonvariable flanking regions were
designed for locus-specific amplification. Primer3 software (available from http:
//www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi) was used for primer
design. On the basis of the results of preliminary studies of amplification effi-
ciency (detailed in Results), species specificity, and the polymorphism observed,
3 of the 11 previously selected sequences were selected for further characteriza-
tion and for application in strain identification. A microsatellite marker, marker
B, previously described for use for C. parapsilosis strain typing (18), was also
included in this study. Marker B was chosen from among the previously de-
scribed microsatellite markers due to its higher degree of polymorphism. The
microsatellite sequences selected and their repetitive motifs, the primers used for
PCR amplification, and the expected fragment sizes are presented in Table 1.
Yeast strains and DNA extraction. A total of 236 independent C. parapsilosis
isolates, including 100 from blood cultures, 9 from the respiratory tract, 27 from
skin and nails, 58 from other body sources, 39 from the environment (including
hospital air and surfaces), type strain ATCC 22019, and reference strains
PNAEQ008-1/2004 and NQ7356/1850 (clinical isolates used for quality control
purposes), were selected for use in this study. Most of them were collected from
different places in Portugal, but collections of isolates that included those from
a variety of geographical origins were also analyzed. These collections were
obtained from France, Spain, the United States, and Peru. The type strains of C.
albicans (ATCC 18804), C. krusei (ATCC 6258), C. tropicalis (ATCC 750), C.
glabrata (ATCC 2001), C. bracarensis (NCYC D3853), C. guilliermondii (ATCC
6260), C. lusitaniae (ATCC 34449), C. dubliniensis (CBS 7987), C. orthopsilosis
(ATCC 96139), C. metapsilosis (ATCC 96144), and Lodderomyces elongisporus
(ATCC 22688) were also tested. One isolate of Aspergillus fumigatus as well as
isolates of the bacteria Escherichia coli and Staphylococcus aureus, obtained from
the culture collection of our laboratory, were also included in this study. All C.
parapsilosis isolates were identified by using ID 32C strips or Vitek YBC iden-
tification cards (bioMe´rieux, SA, Marcy l’E´toile, France) and by PCR finger-
printing with primer T3B by using the methodology described previously (6).
Stock cultures were maintained on Sabouraud glucose agar medium at 4°C. Prior
to DNA isolation, yeast cells were grown for 24 h on Sabouraud glucose agar
medium at 37°C. DNA extraction was performed by using a High Pure PCR
template kit (Roche Diagnostics Corp., Indianapolis, IN), according to the man-
ufacturer’s instructions.
PCR amplification conditions. For all microsatellite loci, PCRs were per-
formed with several different strains to evaluate the locus-specific amplification.
Loci CP1, CP4, and CP6 (their selection is described in Results) were amplified
by using 25 ng of genomic DNA in a 25-l reaction volume containing 1 PCR
buffer, 0.2 mM each four deoxynucleoside triphosphates, 1.5 mM MgCl2, 0.25
M each primer, and 1 U of Taq polymerase (Applied Biosystems, Inc., Foster
City, CA). After a 95°C preincubation step for 2 min, PCR amplifications were
performed in a total of 28 cycles under the following conditions: denaturation at
94°C for 30 s, annealing at 54 to 60°C (depending on the locus) for 30 s, and
extension at 72°C for 1 min and with a final extension step of 7 min at 72°C.
Fragment size determination and DNA sequence analysis. Following PCR, the
amplification products were diluted 1:10 with distilled water and a 1-l aliquot
was added to 13.7 l of formamide and 0.3 l of the internal size standard
(GenScan 500 6-carboxytetramethylrhodamine [TAMRA]; Applied Biosystems,
Inc.). The samples were denatured at 95°C for 5 min and rapidly chilled on ice.
The samples were run on an ABI 310 genetic analyzer (Applied Biosystems). For
accurate allele size determination, the forward primers were fluorescently la-
beled with tetrachloro-6-carboxyfluorescein (TET), 6-carboxyhexafluorescein
(HEX), or 6-carboxyfluorescein (FAM) (Table 1) and the sizes of the PCR
products were determined by using GeneScan (version 3.7) analysis software.
The alleles have been designated by their sizes (in base pairs).
For DNA sequence analysis, only homozygous strains were selected. After
PCR amplification, the products were purified with Microspin S-300 HR columns
(Pharmacia). The purified products were subjected to a dideoxy cycle sequencing
reaction with a BigDye Terminator cycle sequencing ready reaction kit (Applied
Biosystems). Sequence analysis was performed on an ABI 310 genetic analyzer.
RFLP, RAPD, and ITS sequencing. RFLP, RAPD, and ITS analyses were
performed as described previously (38).
Stability. Three different clinical isolates and the reference strains were grown
in 1-liter Erlenmeyer flasks containing 500 ml of Sabouraud medium and incu-
bated at 30°C in an orbital shaker (160 rpm). At the end of the exponential
phase, a 1/10 dilution with new medium was made in order to allow the contin-
uation of cell duplication. This procedure went on for 4 weeks, until the com-
pletion of about 300 generations. The cells were harvested at the end of approx-
imately 100, 200, and 300 generations; and the DNA was extracted for
amplification.
Reproducibility. The reproducibility of the microsatellite method was assessed
systematically by including a reference strain as a control in each run. In addition,
samples were included in some runs in coded replicates, prepared by coinvesti-
gators not involved in that microsatellite run (blind testing; see Results).
Statistical analysis. Allelic and genotypic frequencies were determined by
using ARLEQUIN (version 2.000) software, and the discriminatory power of the
markers was calculated as described by Hunter and Gaston (15).
RESULTS
Screening and selection of repeat regions in C. parapsilosis
genome sequence database. The search of the genomic DNA
database for C. parapsilosis sequences that was performed pro-
vided 1,000 sequences when AAC, AAG, AAT, CCA, CCG,
CTT, CAAA, and AACA queries were used. Selection of the
sequences was primarily based on the number of simple units
repeated. The criteria defined were that the sequence should
be at least 20 repeats, given that these sequences have a higher
TABLE 1. Microsatellite DNA sequences selected, sequence codes, and primers used for PCR amplificationa
Microsatellite
designation Accession no.
b Primer sequencec Repetitivemotif
Expected fragment
size (bp) Dye label
CP1 cpara1131h11.p1k FWD: 5-AAAGTGCTACACACGCATCG-3 (AAG)27 249 TET
REV: 5-GGCTTGCAATTTCATTTCCT-3
CP4 cpara838b06.q1k FWD: 5-CAAATCATCCAGCTTCAAACC-3 (AAC)29 299 HEX
REV: 5-CATCAAACAAGAATTCGATATCAC-3
CP6 cpara692b10.q1k FWD: 5-CAGGAACAGGACAATGGTGA-3 (AAC)48 300 FAM
REV: 5-TCTGGAGCCTCTAGGACGTTT-3
B5d FWD: 5-AGGTTTGTAGTAGTGTCCCTATGG-3 (CA)30 FAM
REV: 5-TATCTCTCTCGCCATTTGAACG-3
a The numbers of repeated units and the predicted sizes of the PCR amplification products were calculated according to the sequence of the strain used in the
sequencing project.
b Code attributed to the sequence in the Sanger Institute.
c FWD, forward primer; REV, reverse primer.
d Details are provided in reference 16.
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probability of showing greater genetic variability, and they
should be located outside known coding regions, since a higher
degree of polymorphism is expected in these regions less prone
to selective forces (12, 24, 28). Subsequently, another selection
was made for sequences that allowed the design of primers
with an annealing temperature above 54°C to ensure specificity
and good reproducibility. Eleven sequences met our criteria
and were selected for locus-specific primer design and ampli-
fication in studies with a set of independent C. parapsilosis
strains. The nomenclature chosen for the new markers was CP,
after C. parapsilosis, followed by a number that corresponded
to the order in which they were studied in the pilot experi-
ments. On the basis of the results of the amplification of DNA
from 23 selected C. parapsilosis strains, seven markers did not
show suitable amplification efficiencies and two markers, al-
though they were chosen from different sequences, turned out
to be the same locus. The remaining three, CP1, CP4, and CP6,
gave satisfactory results with regard to the selection criteria
and were used for further characterization. Table 1 shows the
chosen loci and the respective repetitive motifs, the numbers of
repetitions, as well as the expected PCR product size, accord-
ing to the database sequence.
Sequence analysis. Several representative alleles have been
sequenced, and sequencing analysis of the amplified fragments
revealed that the consensus sequences were in accordance with
those originally published (Table 1), confirming the locus-spe-
cific amplification and structure of the alleles. A direct corre-
lation between the fragment size and the number of microsat-
ellite repeats was found for all the markers, with the
differences in fragment sizes being consistent with the variation
in the number of repetitions.
Specificity and stability. These markers were revealed to be
species specific, since no amplification products were obtained
when the primers and PCR conditions described were used for
the screening of other pathogenic Candida species, namely, C.
albicans, C. krusei, C. tropicalis, C. glabrata, C. bracarensis, C.
guilliermondii, C. lusitaniae, C. dubliniensis, and C. metapsilosis.
Faint amplification was detected with microsatellite CP6 by
analysis with GeneScan software when strains of C. orthopsi-
losis were tested. Raising the PCR annealing temperature to
60°C for the amplification of marker CP6 eliminated the am-
plicons of the C. orthopsilosis strains. This alteration did not
interfere with the amplification of the C. parapsilosis isolates.
No PCR products were obtained when DNA from Loddero-
myces elongisporus, a species closely related to and recently
described in cases of bloodstream infections misidentified as C.
parapsilosis, was amplified (22). Likewise, no amplification was
obtained with the fungus Aspergillus fumigatus or with the bac-
teria Escherichia coli and Staphylococcus aureus.
The in vitro stability of the microsatellites was followed over
300 generations. For all the strains tested, the genotypes were
the same after these generations, suggesting that their ex-
pected mutation rate is less than 3.33  103. Similar results
have previously been reported for C. albicans microsatellites
(32, 33).
Microsatellite locus analysis. The microsatellites selected
were used to type 236 independent C. parapsilosis isolates,
including clinical isolates from different origins and environ-
mental strains, in order to evaluate their specific amplifications
and polymorphisms. One or two PCR fragments per locus were
obtained for each strain, and since C. parapsilosis is a diploid
species (5), each fragment was assigned to an allele. The
strains showing two PCR products were typed as heterozygous,
while strains presenting a single amplification product were
considered homozygous. Less intense stutter bands were fre-
quently present, reflecting polymerase slippage during the
PCR, but they did not present any problem with the identifi-
cation of the correct fragment since they were of a lower
intensity. No PCR products were obtained with the new mic-
rosatellite markers from three bloodstream isolates assigned to
the species C. parapsilosis. These isolates were further analyzed
by sequencing of the ITS and D1/D2 regions of the 26S rDNA.
This showed that two of the isolates were indeed C. metapsi-
losis strains and that the other was a strain of C. orthopsilosis.
PCR products were obtained for all the other 233 C. parapsi-
losis isolates at all three loci, resulting in 100% typeability.
The analysis of the 233 isolates showed that all the micro-
satellite loci were polymorphic, presenting between 20 and 42
alleles and from 39 to 92 different genotypes. The size ranges
of the alleles as well as the corresponding number of repeats
are shown in Table 2. A significant departure from Hardy-
Weinberg equilibrium expectations was found (P  0.001),
supporting the suggestion that inheritance in C. parapsilosis is
mainly clonal, as has been inferred by other authors (36).
The discriminatory power (DP) was calculated for each
marker according to the Simpson index:
DP 1
1
NN 1
j 	 1
S
njnj  1
where N is the number of strains, s is the total number of
different genotypes, and nj is the number of strains of genotype
j (15). The results showed that CP6 was the microsatellite with
the highest DP value (0.96), while CP1 presented the lowest
DP value (0.85). Microsatellite marker B produced 22 different
alleles and 40 genotypes, resulting in a discriminatory power of
0.86 (18). The total number of different alleles and genotypes
TABLE 2. Characteristics of the microsatellite loci selected
Microsatellite
designation
No. of
alleles
Size range
(bp) No. of repeats Allele frequency
a No. of genotypes Genotype frequencya DP %heterozygosity
CP1 20 207–270 14–35 0.002–0.352 39 0.004–0.279 0.85 73.3
CP4 42 240–426 10–72 0.002–0.307 68 0.004–0.27 0.89 21.4
CP6 42 177–375 7–73 0.002–0.176 92 0.004–0.129 0.96 52.3
B5 22 95–153 0.002–0.397 40 0.004–0.33 0.86 30.0
Multiplex 192 0.004–0.047 0.99
a Values are minimums-maximums.
VOL. 48, 2010 MICROSATELLITES FOR DIFFERENTIATION OF C. PARAPSILOSIS 1679
and the respective frequencies obtained for all microsatellite
markers are presented in Table 2.
In the multiplex analysis with markers CP1, CP4, CP6, and
B, a total of 192 multilocus genotypes were obtained and the
combined discriminatory power was 0.99. An example of a
multilocus GeneScan profile is shown in Fig. 1. The great
majority of the multilocus genotypes were found only once
(79%). The most frequently detected multilocus genotype was
shared by 11 independent widespread strains, and the 13 most
frequently detected multilocus genotype accounted for 21% of
the isolates (Table 3).
Comparison of results of different C. parapsilosis typing
methods. Thirty isolates of the C. parapsilosis family typed by
ITS sequencing, RFLP analysis, and RAPD analysis were se-
lected for genotyping with the microsatellite markers described
above so that the results of the microsatellite marker genotyp-
ing method could be compared with those of the other typing
methods. Ten isolates of C. orthopsilosis and C. metapsilosis
strains (including one C. metapsilosis isolate and one C. orthop-
silosis isolate, each included in triplicate as a blind reproduc-
ibility test) were correctly identified as not C. parapsilosis sensu
stricto (these would be RAPD groups B and C and RFLP
groups other than VII-1). The results of microsatellite geno-
typing of the isolates determined to be C. parapsilosis sensu
stricto are shown in Table 4. Fourteen different multilocus
genotypes were obtained. Two isolates of C. parapsilosis sensu
stricto (RAPD group A, RFLP group VII-1) were included in
triplicate (isolates IMR013, IMR160, and IMR339 and isolates
IMR073, IMR320, and IMR 327, respectively) as a blind re-
producibility test, and the isolates in each triplet were correctly
identified to be identical.
Thus, from 15 truly unique isolates, 14 different multilocus
genotypes were obtained. Two C. parapsilosis sensu stricto
isolates, isolates IMR649 and IMR013 (and blind replicate
isolates of IMR013, isolates IMR160 and IMR339) could not
be distinguished by microsatellite typing (nor could they be
distinguished by RFLP, RAPD, or ITS1 typing). These two
isolates originally came from two different sites (the mouth and
the vagina) from patients in two different cities in England
(Leeds and London) (although the overall collection studied
[36, 38] came from a broad geographic background) in the
early 1970s (and were possibly collected in the same year). The
two isolates came from two different sets of isolates gathered
by the same researcher in both places and presumably came
from two different patients. Although one cannot completely
exclude the possibility that they were the same patient who
may have been involved in two different studies, the best ex-
planation is that two patients were infected with the same
genotype, and whether there was any connection between the
patients is unknown.
Two unique isolates are special cases. Both had discrepant
RAPD results in two laboratories (36, 38), with one laboratory
grouping them with C. parapsilosis sensu stricto and the other
not. These were not RFLP type VII-1, which is generally syn-
onymous with C. parapsilosis sensu stricto (38), and were more
consistent with C. orthopsilosis types, as delineated by RFLP
analysis, whereas they were grouped with C. parapsilosis sensu
stricto by ITS1 sequencing. Thus, it was tentatively concluded
(38) either that RFLP analysis can differentiate a few types of
C. parapsilosis sensu stricto that ITS typing cannot or that these
isolates represented some hybrid group sharing some charac-
teristics with C. parapsilosis sensu stricto and C. orthopsilosis.
By microsatellite typing, one of these two isolates was deter-
mined not to be C. parapsilosis sensu stricto, tentatively group-
ing the isolate with C. orthopsilosis and C. metapsilosis (data
not shown). The other isolate (isolate IMR082 in Table 4) was
determined to be C. parapsilosis sensu stricto by microsatellite
typing.
DISCUSSION
A variety of strain typing methods have been used for the
differentiation of the C. parapsilosis family, including electro-
phoretic karyotype (EK) analysis (9, 35), DNA fingerprinting
with probe Cp3-13 (11), RAPD analysis (10, 42), RFLP anal-
ysis (38, 39), multilocus sequence typing (MLST) (36), and
pyrosequencing (2). van Asbeck et al. (38) compared three of
these molecular typing methods, ITS sequencing, RAPD anal-
FIG. 1. GenScan profile obtained by multilocus analysis with the markers CP1 (green), CP4 (black), CP6 (blue), and B (blue). The strain
analyzed is homozygous for markers CP4 and B and heterozygous for markers CP1 and CP6.
TABLE 3. Most common multilocus genotypes found among the
isolates analyzed and their respective frequencies
Multilocus genotypea No. of isolates
with common
multilocus
genotype
Frequency
CP1 CP4 CP6 B
222/243 354/354 282/282 129/129 5 0.021
222/243 354/354 282/336 127/127 3 0.013
222/243 354/354 282/336 129/129 11 0.047
222/243 354/354 282/339 129/129 4 0.017
222/243 354/354 321/321 129/129 4 0.017
222/243 354/354 336/336 129/129 5 0.021
222/243 354/354 339/339 129/129 2 0.009
240/243 342/342 285/285 103/103 4 0.017
240/243 360/360 273/321 129/129 2 0.009
240/252 300/300 285/285 147/149 3 0.013
240/252 300/300 285/285 149/149 2 0.009
243/246 354/354 300/318 127/129 2 0.009
243/249 294/294 261/309 131/131 2 0.009
a The numbers before and after the slashes indicate the fragment sizes (bp) of
the different alleles obtained with the indicated marker.
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ysis, and RFLP analysis, and indicated that ITS1 typing and
RFLP analysis appear to have similar potentials to differenti-
ate C. parapsilosis and both have discriminatory abilities supe-
rior to the discriminatory ability of RAPD analysis. This infe-
riority of RAPD analysis was also true for other methods,
which subdivide the C. parapsilosis sensu lato complex into only
three or a few more groups, as ITS sequencing and RFLP
analysis are able to subtype RAPD type B/group II/C. orthop-
silosis. However, the inability of ITS1 typing and RFLP analysis
to subtype the dominant group, group I/C. parapsilosis sensu
stricto, has been an obstacle.
The only previously reported method able to distinguish
isolates within the C. parapsilosis sensu stricto group is a mic-
rosatellite method based on dinucleotide repeats, but the com-
bined DP of 0.97 achieved for all seven loci was not optimal
(18). Furthermore, the typing of dinucleotide microsatellites
presents limitations for accurate allele identification, even in
automatic systems, owing to the high frequency of dinucleotide
repeat slippage.
Analysis of microsatellite loci has an advantage over other
commonly used typing methods because microsatellite loci be-
have as codominant markers, evolve rapidly in the genome,
and may be able to distinguish between isolates and detect
microevolutionary variations (32). The microsatellite genotyp-
ing of several yeast species, namely, Saccharomyces cerevisiae
(14), C. albicans (3, 4, 33), C. krusei (34), and C. glabrata (13),
has been described.
In the present report, we described new microsatellite mark-
ers for C. parapsilosis sensu stricto. In a multilocus analysis, 192
genotypes were found among 233 isolates, resulting in a DP of
0.99, much higher than that published previously. This micro-
satellite method would therefore be a more robust method for
epidemiologic purposes than RFLP analysis, RAPD analysis,
MLST, or ITS1 sequencing. None of those methods can dis-
tinguish isolates, possibly with rare exceptions (38), coincident
with the most common group encountered in patients or the
environment, C. parapsilosis sensu stricto. The reproducibility
of this microsatellite method was demonstrated by the inclu-
sion of replicates in blind testing. Isolates of the related species
C. orthopsilosis, C. metapsilosis, and L. elongisporus, isolates of
other Candida species, and isolates of other fungal and bacte-
rial species were not confused with C. parapsilosis sensu stricto.
The high degree of polymorphism observed could be corre-
lated with a high mutation rate, which would eventually limit
the use of these markers for strain identification. However, our
results demonstrate that these microsatellites are relatively
stable in laboratory culture, with the estimated mutation rate
being less than 3  103. Mutation rates for microsatellites can
range from 102 to 106, while point mutations are known to
accumulate more slowly, at approximately 109 mutations per
generation (8, 29). Therefore, for outbreak investigations,
which usually span short time intervals, we believe that the
microsatellites are suitable markers.
In conclusion, these new microsatellites are a valuable tool
for use for the differentiation of C. parapsilosis strains and for
application in studies that must distinguish epidemiologically
related isolates, study nosocomial cross-transmission, and
study the kinetics of the colonization-to-infection process. This
method is easy to perform, discriminatory, and highly repro-
ducible, constituting the ideal method for use in large-scale
epidemiological studies. The standardization of the microsat-
ellite typing systems and the creation of public databases that
would make microsatellite allele data available worldwide are
essential issues that deserve attention.
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